+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Transdermal Patches Market - Global Forecast 2026-2032- Product Image
Transdermal Patches Market - Global Forecast 2026-2032- Product Image
New

Transdermal Patches Market - Global Forecast 2026-2032

  • PDF Icon

    Report

  • 188 Pages
  • January 2026
  • Region: Global
  • 360iResearch™
  • ID: 5519528
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The transdermal patches market is on an upward trajectory, driven by material innovation, regulatory advancements, and increasing patient demand for non-invasive drug delivery. This report empowers senior decision-makers with actionable intelligence on key dynamics shaping the sector’s future.

Market Snapshot: Transdermal Patches Market Size and Growth Drivers

The Transdermal Patches Market grew from USD 8.34 billion in 2025 to USD 8.77 billion in 2026, with expectations to reach USD 12.01 billion by 2032 at a CAGR of 5.33%. Growth is fostered by the adoption of advanced adhesives, demand for outpatient care, and a dynamic regulatory landscape. Market momentum is further sustained by demographic shifts and payer interest in therapies supporting continuous care and home-based solutions.

Scope & Segmentation

  • Product Types: Drug-in-Adhesive Patches, Matrix Patches, Micro-Reservoir Patches, each featuring either single or multi-layer architectures that influence drug loading and adhesion.
  • Active Ingredients: Core therapeutics include buprenorphine, clonidine, fentanyl, lidocaine, and nicotine, each selected for distinct pharmacokinetic and safety characteristics.
  • Delivery Mechanics: Controlled-release and direct-release models support different therapies, balancing plasma level steadiness and acute response needs.
  • Clinical Applications: Covers cardiovascular disorders, hormone replacement, neurological conditions, pain management, smoking cessation, and wound care, with tailored patch formats for each indication.
  • End-User Settings: Ambulatory surgical centers, homecare providers, hospitals, clinics, and research institutions, each requiring specific packaging, training, and distribution approaches.
  • Layer Types: Single-layer and multi-layer structures determine manufacturing complexity and cost dynamics.
  • Regional Focus: Americas, Europe, Middle East & Africa, and Asia-Pacific, addressing variable regulatory pathways, production considerations, and adoption trends.

Key Takeaways: Strategic Insights for Senior Leaders

  • Material innovation—such as next-generation adhesives and micro-reservoir engineering—is enabling longer-lasting patches and a broader range of drug candidates for transdermal delivery.
  • Regulatory shifts are clarifying approval processes for combination drug-device products, encouraging more strategic planning and cross-functional collaboration among manufacturers and developers.
  • Patient and provider demand is growing for sustained-release formats that support less frequent dosing and improved adherence, especially in chronic and home-based care environments.
  • Tariff and supply chain pressures are influencing sourcing strategies, with a shift toward regional manufacturing, alternative vendor qualification, and vertical integration to uphold supply resilience.
  • Digital adherence tools and real-world evidence collection are increasingly integrated into product value propositions, fostering better payer engagement and market access potential.
  • Competitive advantages are established through platform technologies that support rapid reformulation for new molecules and through strategic licensing and alliances in both established and emerging markets.

Tariff Impact: Implications for Transdermal Manufacturing and Supply Chain

Tariff measures introduced in 2025 have significantly impacted global transdermal supply chains. Procurement teams are revisiting sourcing and inventory strategies, driving supplier diversification and development of regional manufacturing capacity. Manufacturers are also seeking process efficiencies to offset increased costs, emphasizing quality validation and regulatory compliance in new supply relationships. These changes are prompting commercial teams to adapt pricing strategies and pursue reformulation where feasible, reducing dependence on tariff-exposed materials.

Methodology & Data Sources

This report synthesizes primary interviews with formulation scientists, manufacturing heads, regulatory professionals, and commercial strategists. Secondary research draws from peer-reviewed literature, regulatory guidance, and patent analyses. Triangulated data ensures actionable, validated findings for all stakeholder groups.

Why This Report Matters

  • Segmented intelligence enables precise alignment of development, manufacturing, and commercial strategies with target end-user requirements.
  • Insight into regulatory and supply chain dynamics empowers more resilient sourcing, faster regional approvals, and optimized pricing models.
  • Evidence-based recommendations drive informed investment in platform technologies and partnership models, unlocking differentiated market positioning.

Conclusion

The transdermal patch market’s evolution reflects deeper integration of technology, supply resilience, and evidence-led differentiation. Organizations aligning innovation, operational excellence, and regulatory agility will capitalize on emerging opportunities and foster sustained market impact.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. Market Share Analysis, 2025
3.5. FPNV Positioning Matrix, 2025
3.6. New Revenue Opportunities
3.7. Next-Generation Business Models
3.8. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Porter’s Five Forces Analysis
4.4. PESTLE Analysis
4.5. Market Outlook
4.5.1. Near-Term Market Outlook (0-2 Years)
4.5.2. Medium-Term Market Outlook (3-5 Years)
4.5.3. Long-Term Market Outlook (5-10 Years)
4.6. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of United States Tariffs 2025
7. Cumulative Impact of Artificial Intelligence 2025
8. Transdermal Patches Market, by Product Type
8.1. Drug-In-Adhesive Patches
8.1.1. Multi-Layer Drug-In-Adhesive Patches
8.1.2. Single-Layer Drug-In-Adhesive Patches
8.2. Matrix Patches
8.2.1. Multi-Layer Matrix
8.2.2. Single-Layer Matrix
8.3. Micro-Reservoir Patches
9. Transdermal Patches Market, by Active Ingredient
9.1. Buprenorphine
9.2. Clonidine
9.3. Fentanyl
9.4. Lidocaine
9.5. Nicotine
10. Transdermal Patches Market, by Delivery System
10.1. Controlled Release
10.2. Direct Release
11. Transdermal Patches Market, by Application
11.1. Cardiovascular Disorders
11.1.1. Clonidine Patches
11.1.2. Isosorbide Dinitrate Patches
11.2. Hormone Replacement Therapy
11.2.1. Combination Hormone Patches
11.2.2. Estrogen Patches
11.2.3. Progestin Patches
11.3. Neurological Conditions
11.4. Pain Management
11.4.1. Diclofenac-Based
11.4.2. Fentanyl-Based
11.4.3. Lidocaine-Based
11.5. Smoking Cessation
11.6. Wound Management
12. Transdermal Patches Market, by End User
12.1. Ambulatory Surgical Centers
12.2. Homecare Settings
12.3. Hospitals & Clinics
12.4. Research & Academic Institutes
13. Transdermal Patches Market, by Layer Type
13.1. Multi-Layer
13.2. Single Layer
14. Transdermal Patches Market, by Region
14.1. Americas
14.1.1. North America
14.1.2. Latin America
14.2. Europe, Middle East & Africa
14.2.1. Europe
14.2.2. Middle East
14.2.3. Africa
14.3. Asia-Pacific
15. Transdermal Patches Market, by Group
15.1. ASEAN
15.2. GCC
15.3. European Union
15.4. BRICS
15.5. G7
15.6. NATO
16. Transdermal Patches Market, by Country
16.1. United States
16.2. Canada
16.3. Mexico
16.4. Brazil
16.5. United Kingdom
16.6. Germany
16.7. France
16.8. Russia
16.9. Italy
16.10. Spain
16.11. China
16.12. India
16.13. Japan
16.14. Australia
16.15. South Korea
17. United States Transdermal Patches Market
18. China Transdermal Patches Market
19. Competitive Landscape
19.1. Market Concentration Analysis, 2025
19.1.1. Concentration Ratio (CR)
19.1.2. Herfindahl Hirschman Index (HHI)
19.2. Recent Developments & Impact Analysis, 2025
19.3. Product Portfolio Analysis, 2025
19.4. Benchmarking Analysis, 2025
19.5. AbbVie Inc.
19.6. AdhexPharma SAS
19.7. Amneal Pharmaceuticals, Inc.
19.8. Bayer AG
19.9. BioNxt Solutions Inc.
19.10. Bliss GVS Pharma Ltd.
19.11. Boehringer Ingelheim International GmbH
19.12. Corium, Inc.
19.13. Corsair Pharma, Inc.
19.14. DifGen Pharmaceuticals LLC
19.15. Endo International plc
19.16. Gedeon Richter Plc
19.17. GlaxoSmithKline Plc
19.18. Icure Pharmaceutical Inc.
19.19. Johnson & Johnson Services, Inc.
19.20. LAVIPHARM GROUP HOLDING S.A.
19.21. Lohmann Therapie-Systeme AG
19.22. Luye Pharma Group Ltd
19.23. Medherant Limited
19.24. Nitto Denko Corporation
19.25. Novartis AG
19.26. Noven Pharmaceuticals, Inc. by Hisamitsu Pharmaceutical Co., Inc.
19.27. Nutriband Inc
19.28. Perrigo Company plc
19.29. ProSolus, Inc.
19.30. Purdue Pharma L.P.
19.31. Sparsha Pharma International Pvt Ltd
19.32. Teikoku Seiyaku Co., Ltd.
19.33. Teva Pharmaceutical Industries Ltd.
19.34. Viatris Inc.
19.35. Zydus Group
List of Figures
FIGURE 1. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 2. GLOBAL TRANSDERMAL PATCHES MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 3. GLOBAL TRANSDERMAL PATCHES MARKET, FPNV POSITIONING MATRIX, 2025
FIGURE 4. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 5. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY ACTIVE INGREDIENT, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 6. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY DELIVERY SYSTEM, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 7. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 9. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY LAYER TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 11. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 12. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 13. UNITED STATES TRANSDERMAL PATCHES MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 14. CHINA TRANSDERMAL PATCHES MARKET SIZE, 2018-2032 (USD MILLION)
List of Tables
TABLE 1. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 2. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 3. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY DRUG-IN-ADHESIVE PATCHES, BY REGION, 2018-2032 (USD MILLION)
TABLE 4. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY DRUG-IN-ADHESIVE PATCHES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 5. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY DRUG-IN-ADHESIVE PATCHES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 6. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY DRUG-IN-ADHESIVE PATCHES, 2018-2032 (USD MILLION)
TABLE 7. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY MULTI-LAYER DRUG-IN-ADHESIVE PATCHES, BY REGION, 2018-2032 (USD MILLION)
TABLE 8. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY MULTI-LAYER DRUG-IN-ADHESIVE PATCHES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 9. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY MULTI-LAYER DRUG-IN-ADHESIVE PATCHES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 10. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY SINGLE-LAYER DRUG-IN-ADHESIVE PATCHES, BY REGION, 2018-2032 (USD MILLION)
TABLE 11. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY SINGLE-LAYER DRUG-IN-ADHESIVE PATCHES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 12. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY SINGLE-LAYER DRUG-IN-ADHESIVE PATCHES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 13. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY MATRIX PATCHES, BY REGION, 2018-2032 (USD MILLION)
TABLE 14. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY MATRIX PATCHES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 15. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY MATRIX PATCHES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 16. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY MATRIX PATCHES, 2018-2032 (USD MILLION)
TABLE 17. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY MULTI-LAYER MATRIX, BY REGION, 2018-2032 (USD MILLION)
TABLE 18. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY MULTI-LAYER MATRIX, BY GROUP, 2018-2032 (USD MILLION)
TABLE 19. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY MULTI-LAYER MATRIX, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 20. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY SINGLE-LAYER MATRIX, BY REGION, 2018-2032 (USD MILLION)
TABLE 21. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY SINGLE-LAYER MATRIX, BY GROUP, 2018-2032 (USD MILLION)
TABLE 22. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY SINGLE-LAYER MATRIX, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 23. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY MICRO-RESERVOIR PATCHES, BY REGION, 2018-2032 (USD MILLION)
TABLE 24. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY MICRO-RESERVOIR PATCHES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 25. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY MICRO-RESERVOIR PATCHES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 26. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY ACTIVE INGREDIENT, 2018-2032 (USD MILLION)
TABLE 27. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY BUPRENORPHINE, BY REGION, 2018-2032 (USD MILLION)
TABLE 28. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY BUPRENORPHINE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 29. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY BUPRENORPHINE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 30. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY CLONIDINE, BY REGION, 2018-2032 (USD MILLION)
TABLE 31. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY CLONIDINE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 32. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY CLONIDINE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 33. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY FENTANYL, BY REGION, 2018-2032 (USD MILLION)
TABLE 34. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY FENTANYL, BY GROUP, 2018-2032 (USD MILLION)
TABLE 35. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY FENTANYL, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 36. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY LIDOCAINE, BY REGION, 2018-2032 (USD MILLION)
TABLE 37. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY LIDOCAINE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 38. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY LIDOCAINE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 39. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY NICOTINE, BY REGION, 2018-2032 (USD MILLION)
TABLE 40. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY NICOTINE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 41. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY NICOTINE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 42. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY DELIVERY SYSTEM, 2018-2032 (USD MILLION)
TABLE 43. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY CONTROLLED RELEASE, BY REGION, 2018-2032 (USD MILLION)
TABLE 44. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY CONTROLLED RELEASE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 45. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY CONTROLLED RELEASE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 46. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY DIRECT RELEASE, BY REGION, 2018-2032 (USD MILLION)
TABLE 47. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY DIRECT RELEASE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 48. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY DIRECT RELEASE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 49. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 50. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY CARDIOVASCULAR DISORDERS, BY REGION, 2018-2032 (USD MILLION)
TABLE 51. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY CARDIOVASCULAR DISORDERS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 52. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY CARDIOVASCULAR DISORDERS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 53. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY CARDIOVASCULAR DISORDERS, 2018-2032 (USD MILLION)
TABLE 54. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY CLONIDINE PATCHES, BY REGION, 2018-2032 (USD MILLION)
TABLE 55. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY CLONIDINE PATCHES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 56. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY CLONIDINE PATCHES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 57. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY ISOSORBIDE DINITRATE PATCHES, BY REGION, 2018-2032 (USD MILLION)
TABLE 58. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY ISOSORBIDE DINITRATE PATCHES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 59. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY ISOSORBIDE DINITRATE PATCHES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 60. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY HORMONE REPLACEMENT THERAPY, BY REGION, 2018-2032 (USD MILLION)
TABLE 61. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY HORMONE REPLACEMENT THERAPY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 62. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY HORMONE REPLACEMENT THERAPY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 63. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY HORMONE REPLACEMENT THERAPY, 2018-2032 (USD MILLION)
TABLE 64. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY COMBINATION HORMONE PATCHES, BY REGION, 2018-2032 (USD MILLION)
TABLE 65. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY COMBINATION HORMONE PATCHES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 66. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY COMBINATION HORMONE PATCHES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 67. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY ESTROGEN PATCHES, BY REGION, 2018-2032 (USD MILLION)
TABLE 68. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY ESTROGEN PATCHES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 69. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY ESTROGEN PATCHES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 70. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY PROGESTIN PATCHES, BY REGION, 2018-2032 (USD MILLION)
TABLE 71. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY PROGESTIN PATCHES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 72. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY PROGESTIN PATCHES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 73. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY NEUROLOGICAL CONDITIONS, BY REGION, 2018-2032 (USD MILLION)
TABLE 74. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY NEUROLOGICAL CONDITIONS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 75. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY NEUROLOGICAL CONDITIONS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 76. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY PAIN MANAGEMENT, BY REGION, 2018-2032 (USD MILLION)
TABLE 77. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY PAIN MANAGEMENT, BY GROUP, 2018-2032 (USD MILLION)
TABLE 78. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY PAIN MANAGEMENT, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 79. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY PAIN MANAGEMENT, 2018-2032 (USD MILLION)
TABLE 80. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY DICLOFENAC-BASED, BY REGION, 2018-2032 (USD MILLION)
TABLE 81. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY DICLOFENAC-BASED, BY GROUP, 2018-2032 (USD MILLION)
TABLE 82. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY DICLOFENAC-BASED, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 83. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY FENTANYL-BASED, BY REGION, 2018-2032 (USD MILLION)
TABLE 84. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY FENTANYL-BASED, BY GROUP, 2018-2032 (USD MILLION)
TABLE 85. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY FENTANYL-BASED, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 86. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY LIDOCAINE-BASED, BY REGION, 2018-2032 (USD MILLION)
TABLE 87. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY LIDOCAINE-BASED, BY GROUP, 2018-2032 (USD MILLION)
TABLE 88. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY LIDOCAINE-BASED, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 89. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY SMOKING CESSATION, BY REGION, 2018-2032 (USD MILLION)
TABLE 90. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY SMOKING CESSATION, BY GROUP, 2018-2032 (USD MILLION)
TABLE 91. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY SMOKING CESSATION, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 92. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY WOUND MANAGEMENT, BY REGION, 2018-2032 (USD MILLION)
TABLE 93. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY WOUND MANAGEMENT, BY GROUP, 2018-2032 (USD MILLION)
TABLE 94. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY WOUND MANAGEMENT, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 95. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 96. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2032 (USD MILLION)
TABLE 97. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 98. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 99. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY HOMECARE SETTINGS, BY REGION, 2018-2032 (USD MILLION)
TABLE 100. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY HOMECARE SETTINGS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 101. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY HOMECARE SETTINGS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 102. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2032 (USD MILLION)
TABLE 103. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY HOSPITALS & CLINICS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 104. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY HOSPITALS & CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 105. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY RESEARCH & ACADEMIC INSTITUTES, BY REGION, 2018-2032 (USD MILLION)
TABLE 106. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY RESEARCH & ACADEMIC INSTITUTES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 107. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY RESEARCH & ACADEMIC INSTITUTES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 108. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY LAYER TYPE, 2018-2032 (USD MILLION)
TABLE 109. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY MULTI-LAYER, BY REGION, 2018-2032 (USD MILLION)
TABLE 110. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY MULTI-LAYER, BY GROUP, 2018-2032 (USD MILLION)
TABLE 111. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY MULTI-LAYER, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 112. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY SINGLE LAYER, BY REGION, 2018-2032 (USD MILLION)
TABLE 113. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY SINGLE LAYER, BY GROUP, 2018-2032 (USD MILLION)
TABLE 114. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY SINGLE LAYER, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 115. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 116. AMERICAS TRANSDERMAL PATCHES MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 117. AMERICAS TRANSDERMAL PATCHES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 118. AMERICAS TRANSDERMAL PATCHES MARKET SIZE, BY DRUG-IN-ADHESIVE PATCHES, 2018-2032 (USD MILLION)
TABLE 119. AMERICAS TRANSDERMAL PATCHES MARKET SIZE, BY MATRIX PATCHES, 2018-2032 (USD MILLION)
TABLE 120. AMERICAS TRANSDERMAL PATCHES MARKET SIZE, BY ACTIVE INGREDIENT, 2018-2032 (USD MILLION)
TABLE 121. AMERICAS TRANSDERMAL PATCHES MARKET SIZE, BY DELIVERY SYSTEM, 2018-2032 (USD MILLION)
TABLE 122. AMERICAS TRANSDERMAL PATCHES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 123. AMERICAS TRANSDERMAL PATCHES MARKET SIZE, BY CARDIOVASCULAR DISORDERS, 2018-2032 (USD MILLION)
TABLE 124. AMERICAS TRANSDERMAL PATCHES MARKET SIZE, BY HORMONE REPLACEMENT THERAPY, 2018-2032 (USD MILLION)
TABLE 125. AMERICAS TRANSDERMAL PATCHES MARKET SIZE, BY PAIN MANAGEMENT, 2018-2032 (USD MILLION)
TABLE 126. AMERICAS TRANSDERMAL PATCHES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 127. AMERICAS TRANSDERMAL PATCHES MARKET SIZE, BY LAYER TYPE, 2018-2032 (USD MILLION)
TABLE 128. NORTH AMERICA TRANSDERMAL PATCHES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 129. NORTH AMERICA TRANSDERMAL PATCHES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 130. NORTH AMERICA TRANSDERMAL PATCHES MARKET SIZE, BY DRUG-IN-ADHESIVE PATCHES, 2018-2032 (USD MILLION)
TABLE 131. NORTH AMERICA TRANSDERMAL PATCHES MARKET SIZE, BY MATRIX PATCHES, 2018-2032 (USD MILLION)
TABLE 132. NORTH AMERICA TRANSDERMAL PATCHES MARKET SIZE, BY ACTIVE INGREDIENT, 2018-2032 (USD MILLION)
TABLE 133. NORTH AMERICA TRANSDERMAL PATCHES MARKET SIZE, BY DELIVERY SYSTEM, 2018-2032 (USD MILLION)
TABLE 134. NORTH AMERICA TRANSDERMAL PATCHES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 135. NORTH AMERICA TRANSDERMAL PATCHES MARKET SIZE, BY CARDIOVASCULAR DISORDERS, 2018-2032 (USD MILLION)
TABLE 136. NORTH AMERICA TRANSDERMAL PATCHES MARKET SIZE, BY HORMONE REPLACEMENT THERAPY, 2018-2032 (USD MILLION)
TABLE 137. NORTH AMERICA TRANSDERMAL PATCHES MARKET SIZE, BY PAIN MANAGEMENT, 2018-2032 (USD MILLION)
TABLE 138. NORTH AMERICA TRANSDERMAL PATCHES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 139. NORTH AMERICA TRANSDERMAL PATCHES MARKET SIZE, BY LAYER TYPE, 2018-2032 (USD MILLION)
TABLE 140. LATIN AMERICA TRANSDERMAL PATCHES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 141. LATIN AMERICA TRANSDERMAL PATCHES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 142. LATIN AMERICA TRANSDERMAL PATCHES MARKET SIZE, BY DRUG-IN-ADHESIVE PATCHES, 2018-2032 (USD MILLION)
TABLE 143. LATIN AMERICA TRANSDERMAL PATCHES MARKET SIZE, BY MATRIX PATCHES, 2018-2032 (USD MILLION)
TABLE 144. LATIN AMERICA TRANSDERMAL PATCHES MARKET SIZE, BY ACTIVE INGREDIENT, 2018-2032 (USD MILLION)
TABLE 145. LATIN AMERICA TRANSDERMAL PATCHES MARKET SIZE, BY DELIVERY SYSTEM, 2018-2032 (USD MILLION)
TABLE 146. LATIN AMERICA TRANSDERMAL PATCHES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 147. LATIN AMERICA TRANSDERMAL PATCHES MARKET SIZE, BY CARDIOVASCULAR DISORDERS, 2018-2032 (USD MILLION)
TABLE 148. LATIN AMERICA TRANSDERMAL PATCHES MARKET SIZE, BY HORMONE REPLACEMENT THERAPY, 2018-2032 (USD MILLION)
TABLE 149. LATIN AMERICA TRANSDERMAL PATCHES MARKET SIZE, BY PAIN MANAGEMENT, 2018-2032 (USD MILLION)
TABLE 150. LATIN AMERICA TRANSDERMAL PATCHES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 151. LATIN AMERICA TRANSDERMAL PATCHES MARKET SIZE, BY LAYER TYPE, 2018-2032 (USD MILLION)
TABLE 152. EUROPE, MIDDLE EAST & AFRICA TRANSDERMAL PATCHES MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 153. EUROPE, MIDDLE EAST & AFRICA TRANSDERMAL PATCHES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 154. EUROPE, MIDDLE EAST & AFRICA TRANSDERMAL PATCHES MARKET SIZE, BY DRUG-IN-ADHESIVE PATCHES, 2018-2032 (USD MILLION)
TABLE 155. EUROPE, MIDDLE EAST & AFRICA TRANSDERMAL PATCHES MARKET SIZE, BY MATRIX PATCHES, 2018-2032 (USD MILLION)
TABLE 156. EUROPE, MIDDLE EAST & AFRICA TRANSDERMAL PATCHES MARKET SIZE, BY ACTIVE INGREDIENT, 2018-2032 (USD MILLION)
TABLE 157. EUROPE, MIDDLE EAST & AFRICA TRANSDERMAL PATCHES MARKET SIZE, BY DELIVERY SYSTEM, 2018-2032 (USD MILLION)
TABLE 158. EUROPE, MIDDLE EAST & AFRICA TRANSDERMAL PATCHES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 159. EUROPE, MIDDLE EAST & AFRICA TRANSDERMAL PATCHES MARKET SIZE, BY CARDIOVASCULAR DISORDERS, 2018-2032 (USD MILLION)
TABLE 160. EUROPE, MIDDLE EAST & AFRICA TRANSDERMAL PATCHES MARKET SIZE, BY HORMONE REPLACEMENT THERAPY, 2018-2032 (USD MILLION)
TABLE 161. EUROPE, MIDDLE EAST & AFRICA TRANSDERMAL PATCHES MARKET SIZE, BY PAIN MANAGEMENT, 2018-2032 (USD MILLION)
TABLE 162. EUROPE, MIDDLE EAST & AFRICA TRANSDERMAL PATCHES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 163. EUROPE, MIDDLE EAST & AFRICA TRANSDERMAL PATCHES MARKET SIZE, BY LAYER TYPE, 2018-2032 (USD MILLION)
TABLE 164. EUROPE TRANSDERMAL PATCHES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 165. EUROPE TRANSDERMAL PATCHES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 166. EUROPE TRANSDERMAL PATCHES MARKET SIZE, BY DRUG-IN-ADHESIVE PATCHES, 2018-2032 (USD MILLION)
TABLE 167. EUROPE TRANSDERMAL PATCHES MARKET SIZE, BY MATRIX PATCHES, 2018-2032 (USD MILLION)
TABLE 168. EUROPE TRANSDERMAL PATCHES MARKET SIZE, BY ACTIVE INGREDIENT, 2018-2032 (USD MILLION)
TABLE 169. EUROPE TRANSDERMAL PATCHES MARKET SIZE, BY DELIVERY SYSTEM, 2018-2032 (USD MILLION)
TABLE 170. EUROPE TRANSDERMAL PATCHES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 171. EUROPE TRANSDERMAL PATCHES MARKET SIZE, BY CARDIOVASCULAR DISORDERS, 2018-2032 (USD MILLION)
TABLE 172. EUROPE TRANSDERMAL PATCHES MARKET SIZE, BY HORMONE REPLACEMENT THERAPY, 2018-2032 (USD MILLION)
TABLE 173. EUROPE TRANSDERMAL PATCHES MARKET SIZE, BY PAIN MANAGEMENT, 2018-2032 (USD MILLION)
TABLE 174. EUROPE TRANSDERMAL PATCHES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 175. EUROPE TRANSDERMAL PATCHES MARKET SIZE, BY LAYER TYPE, 2018-2032 (USD MILLION)
TABLE 176. MIDDLE EAST TRANSDERMAL PATCHES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 177. MIDDLE EAST TRANSDERMAL PATCHES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 178. MIDDLE EAST TRANSDERMAL PATCHES MARKET SIZE, BY DRUG-IN-ADHESIVE PATCHES, 2018-2032 (USD MILLION)
TABLE 179. MIDDLE EAST TRANSDERMAL PATCHES MARKET SIZE, BY MATRIX PATCHES, 2018-2032 (USD MILLION)
TABLE 180. MIDDLE EAST TRANSDERMAL PATCHES MARKET SIZE, BY ACTIVE INGREDIENT, 2018-2032 (USD MILLION)
TABLE 181. MIDDLE EAST TRANSDERMAL PATCHES MARKET SIZE, BY DELIVERY SYSTEM, 2018-2032 (USD MILLION)
TABLE 182. MIDDLE EAST TRANSDERMAL PATCHES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 183. MIDDLE EAST TRANSDERMAL PATCHES MARKET SIZE, BY CARDIOVASCULAR DISORDERS, 2018-2032 (USD MILLION)
TABLE 184. MIDDLE EAST TRANSDERMAL PATCHES MARKET SIZE, BY HORMONE REPLACEMENT THERAPY, 2018-2032 (USD MILLION)
TABLE 185. MIDDLE EAST TRANSDERMAL PATCHES MARKET SIZE, BY PAIN MANAGEMENT, 2018-2032 (USD MILLION)
TABLE 186. MIDDLE EAST TRANSDERMAL PATCHES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 187. MIDDLE EAST TRANSDERMAL PATCHES MARKET SIZE, BY LAYER TYPE, 2018-2032 (USD MILLION)
TABLE 188. AFRICA TRANSDERMAL PATCHES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 189. AFRICA TRANSDERMAL PATCHES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 190. AFRICA TRANSDERMAL PATCHES MARKET SIZE, BY DRUG-IN-ADHESIVE PATCHES, 2018-2032 (USD MILLION)
TABLE 191. AFRICA TRANSDERMAL PATCHES MARKET SIZE, BY MATRIX PATCHES, 2018-2032 (USD MILLION)
TABLE 192. AFRICA TRANSDERMAL PATCHES MARKET SIZE, BY ACTIVE INGREDIENT, 2018-2032 (USD MILLION)
TABLE 193. AFRICA TRANSDERMAL PATCHES MARKET SIZE, BY DELIVERY SYSTEM, 2018-2032 (USD MILLION)
TABLE 194. AFRICA TRANSDERMAL PATCHES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 195. AFRICA TRANSDERMAL PATCHES MARKET SIZE, BY CARDIOVASCULAR DISORDERS, 2018-2032 (USD MILLION)
TABLE 196. AFRICA TRANSDERMAL PATCHES MARKET SIZE, BY HORMONE REPLACEMENT THERAPY, 2018-2032 (USD MILLION)
TABLE 197. AFRICA TRANSDERMAL PATCHES MARKET SIZE, BY PAIN MANAGEMENT, 2018-2032 (USD MILLION)
TABLE 198. AFRICA TRANSDERMAL PATCHES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 199. AFRICA TRANSDERMAL PATCHES MARKET SIZE, BY LAYER TYPE, 2018-2032 (USD MILLION)
TABLE 200. ASIA-PACIFIC TRANSDERMAL PATCHES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 201. ASIA-PACIFIC TRANSDERMAL PATCHES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 202. ASIA-PACIFIC TRANSDERMAL PATCHES MARKET SIZE, BY DRUG-IN-ADHESIVE PATCHES, 2018-2032 (USD MILLION)
TABLE 203. ASIA-PACIFIC TRANSDERMAL PATCHES MARKET SIZE, BY MATRIX PATCHES, 2018-2032 (USD MILLION)
TABLE 204. ASIA-PACIFIC TRANSDERMAL PATCHES MARKET SIZE, BY ACTIVE INGREDIENT, 2018-2032 (USD MILLION)
TABLE 205. ASIA-PACIFIC TRANSDERMAL PATCHES MARKET SIZE, BY DELIVERY SYSTEM, 2018-2032 (USD MILLION)
TABLE 206. ASIA-PACIFIC TRANSDERMAL PATCHES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 207. ASIA-PACIFIC TRANSDERMAL PATCHES MARKET SIZE, BY CARDIOVASCULAR DISORDERS, 2018-2032 (USD MILLION)
TABLE 208. ASIA-PACIFIC TRANSDERMAL PATCHES MARKET SIZE, BY HORMONE REPLACEMENT THERAPY, 2018-2032 (USD MILLION)
TABLE 209. ASIA-PACIFIC TRANSDERMAL PATCHES MARKET SIZE, BY PAIN MANAGEMENT, 2018-2032 (USD MILLION)
TABLE 210. ASIA-PACIFIC TRANSDERMAL PATCHES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 211. ASIA-PACIFIC TRANSDERMAL PATCHES MARKET SIZE, BY LAYER TYPE, 2018-2032 (USD MILLION)
TABLE 212. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 213. ASEAN TRANSDERMAL PATCHES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 214. ASEAN TRANSDERMAL PATCHES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 215. ASEAN TRANSDERMAL PATCHES MARKET SIZE, BY DRUG-IN-ADHESIVE PATCHES, 2018-2032 (USD MILLION)
TABLE 216. ASEAN TRANSDERMAL PATCHES MARKET SIZE, BY MATRIX PATCHES, 2018-2032 (USD MILLION)
TABLE 217. ASEAN TRANSDERMAL PATCHES MARKET SIZE, BY ACTIVE INGREDIENT, 2018-2032 (USD MILLION)
TABLE 218. ASEAN TRANSDERMAL PATCHES MARKET SIZE, BY DELIVERY SYSTEM, 2018-2032 (USD MILLION)
TABLE 219. ASEAN TRANSDERMAL PATCHES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 220. ASEAN TRANSDERMAL PATCHES MARKET SIZE, BY CARDIOVASCULAR DISORDERS, 2018-2032 (USD MILLION)
TABLE 221. ASEAN TRANSDERMAL PATCHES MARKET SIZE, BY HORMONE REPLACEMENT THERAPY, 2018-2032 (USD MILLION)
TABLE 222. ASEAN TRANSDERMAL PATCHES MARKET SIZE, BY PAIN MANAGEMENT, 2018-2032 (USD MILLION)
TABLE 223. ASEAN TRANSDERMAL PATCHES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 224. ASEAN TRANSDERMAL PATCHES MARKET SIZE, BY LAYER TYPE, 2018-2032 (USD MILLION)
TABLE 225. GCC TRANSDERMAL PATCHES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 226. GCC TRANSDERMAL PATCHES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 227. GCC TRANSDERMAL PATCHES MARKET SIZE, BY DRUG-IN-ADHESIVE PATCHES, 2018-2032 (USD MILLION)
TABLE 228. GCC TRANSDERMAL PATCHES MARKET SIZE, BY MATRIX PATCHES, 2018-2032 (USD MILLION)
TABLE 229. GCC TRANSDERMAL PATCHES MARKET SIZE, BY ACTIVE INGREDIENT, 2018-2032 (USD MILLION)
TABLE 230. GCC TRANSDERMAL PATCHES MARKET SIZE, BY DELIVERY SYSTEM, 2018-2032 (USD MILLION)
TABLE 231. GCC TRANSDERMAL PATCHES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 232. GCC TRANSDERMAL PATCHES MARKET SIZE, BY CARDIOVASCULAR DISORDERS, 2018-2032 (USD MILLION)
TABLE 233. GCC TRANSDERMAL PATCHES MARKET SIZE, BY HORMONE REPLACEMENT THERAPY, 2018-2032 (USD MILLION)
TABLE 234. GCC TRANSDERMAL PATCHES MARKET SIZE, BY PAIN MANAGEMENT, 2018-2032 (USD MILLION)
TABLE 235. GCC TRANSDERMAL PATCHES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 236. GCC TRANSDERMAL PATCHES MARKET SIZE, BY LAYER TYPE, 2018-2032 (USD MILLION)
TABLE 237. EUROPEAN UNION TRANSDERMAL PATCHES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 238. EUROPEAN UNION TRANSDERMAL PATCHES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 239. EUROPEAN UNION TRANSDERMAL PATCHES MARKET SIZE, BY DRUG-IN-ADHESIVE PATCHES, 2018-2032 (USD MILLION)
TABLE 240. EUROPEAN UNION TRANSDERMAL PATCHES MARKET SIZE, BY MATRIX PATCHES, 2018-2032 (USD MILLION)
TABLE 241. EUROPEAN UNION TRANSDERMAL PATCHES MARKET SIZE, BY ACTIVE INGREDIENT, 2018-2032 (USD MILLION)
TABLE 242. EUROPEAN UNION TRANSDERMAL PATCHES MARKET SIZE, BY DELIVERY SYSTEM, 2018-2032 (USD MILLION)
TABLE 243. EUROPEAN UNION TRANSDERMAL PATCHES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 244. EUROPEAN UNION TRANSDERMAL PATCHES MARKET SIZE, BY CARDIOVASCULAR DISORDERS, 2018-2032 (USD MILLION)
TABLE 245. EUROPEAN UNION TRANSDERMAL PATCHES MARKET SIZE, BY HORMONE REPLACEMENT THERAPY, 2018-2032 (USD MILLION)
TABLE 246. EUROPEAN UNION TRANSDERMAL PATCHES MARKET SIZE, BY PAIN MANAGEMENT, 2018-2032 (USD MILLION)
TABLE 247. EUROPEAN UNION TRANSDERMAL PATCHES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 248. EUROPEAN UNION TRANSDERMAL PATCHES MARKET SIZE, BY LAYER TYPE, 2018-2032 (USD MILLION)
TABLE 249. BRICS TRANSDERMAL PATCHES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 250. BRICS TRANSDERMAL PATCHES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 251. BRICS TRANSDERMAL PATCHES MARKET SIZE, BY DRUG-IN-ADHESIVE PATCHES, 2018-2032 (USD MILLION)
TABLE 252. BRICS TRANSDERMAL PATCHES MARKET SIZE, BY MATRIX PATCHES, 2018-2032 (USD MILLION)
TABLE 253. BRICS TRANSDERMAL PATCHES MARKET SIZE, BY ACTIVE INGREDIENT, 2018-2032 (USD MILLION)
TABLE 254. BRICS TRANSDERMAL PATCHES MARKET SIZE, BY DELIVERY SYSTEM, 2018-2032 (USD MILLION)
TABLE 255. BRICS TRANSDERMAL PATCHES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 256. BRICS TRANSDERMAL PATCHES MARKET SIZE, BY CARDIOVASCULAR DISORDERS, 2018-2032 (USD MILLION)
TABLE 257. BRICS TRANSDERMAL PATCHES MARKET SIZE, BY HORMONE REPLACEMENT THERAPY, 2018-2032 (USD MILLION)
TABLE 258. BRICS TRANSDERMAL PATCHES MARKET SIZE, BY PAIN MANAGEMENT, 2018-2032 (USD MILLION)
TABLE 259. BRICS TRANSDERMAL PATCHES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 260. BRICS TRANSDERMAL PATCHES MARKET SIZE, BY LAYER TYPE, 2018-2032 (USD MILLION)
TABLE 261. G7 TRANSDERMAL PATCHES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 262. G7 TRANSDERMAL PATCHES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 263. G7 TRANSDERMAL PATCHES MARKET SIZE, BY DRUG-IN-ADHESIVE PATCHES, 2018-2032 (USD MILLION)
TABLE 264. G7 TRANSDERMAL PATCHES MARKET SIZE, BY MATRIX PATCHES, 2018-2032 (USD MILLION)
TABLE 265. G7 TRANSDERMAL PATCHES MARKET SIZE, BY ACTIVE INGREDIENT, 2018-2032 (USD MILLION)
TABLE 266. G7 TRANSDERMAL PATCHES MARKET SIZE, BY DELIVERY SYSTEM, 2018-2032 (USD MILLION)
TABLE 267. G7 TRANSDERMAL PATCHES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 268. G7 TRANSDERMAL PATCHES MARKET SIZE, BY CARDIOVASCULAR DISORDERS, 2018-2032 (USD MILLION)
TABLE 269. G7 TRANSDERMAL PATCHES MARKET SIZE, BY HORMONE REPLACEMENT THERAPY, 2018-2032 (USD MILLION)
TABLE 270. G7 TRANSDERMAL PATCHES MARKET SIZE, BY PAIN MANAGEMENT, 2018-2032 (USD MILLION)
TABLE 271. G7 TRANSDERMAL PATCHES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 272. G7 TRANSDERMAL PATCHES MARKET SIZE, BY LAYER TYPE, 2018-2032 (USD MILLION)
TABLE 273. NATO TRANSDERMAL PATCHES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 274. NATO TRANSDERMAL PATCHES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 275. NATO TRANSDERMAL PATCHES MARKET SIZE, BY DRUG-IN-ADHESIVE PATCHES, 2018-2032 (USD MILLION)
TABLE 276. NATO TRANSDERMAL PATCHES MARKET SIZE, BY MATRIX PATCHES, 2018-2032 (USD MILLION)
TABLE 277. NATO TRANSDERMAL PATCHES MARKET SIZE, BY ACTIVE INGREDIENT, 2018-2032 (USD MILLION)
TABLE 278. NATO TRANSDERMAL PATCHES MARKET SIZE, BY DELIVERY SYSTEM, 2018-2032 (USD MILLION)
TABLE 279. NATO TRANSDERMAL PATCHES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 280. NATO TRANSDERMAL PATCHES MARKET SIZE, BY CARDIOVASCULAR DISORDERS, 2018-2032 (USD MILLION)
TABLE 281. NATO TRANSDERMAL PATCHES MARKET SIZE, BY HORMONE REPLACEMENT THERAPY, 2018-2032 (USD MILLION)
TABLE 282. NATO TRANSDERMAL PATCHES MARKET SIZE, BY PAIN MANAGEMENT, 2018-2032 (USD MILLION)
TABLE 283. NATO TRANSDERMAL PATCHES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 284. NATO TRANSDERMAL PATCHES MARKET SIZE, BY LAYER TYPE, 2018-2032 (USD MILLION)
TABLE 285. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 286. UNITED STATES TRANSDERMAL PATCHES MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 287. UNITED STATES TRANSDERMAL PATCHES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 288. UNITED STATES TRANSDERMAL PATCHES MARKET SIZE, BY DRUG-IN-ADHESIVE PATCHES, 2018-2032 (USD MILLION)
TABLE 289. UNITED STATES TRANSDERMAL PATCHES MARKET SIZE, BY MATRIX PATCHES, 2018-2032 (USD MILLION)
TABLE 290. UNITED STATES TRANSDERMAL PATCHES MARKET SIZE, BY ACTIVE INGREDIENT, 2018-2032 (USD MILLION)
TABLE 291. UNITED STATES TRANSDERMAL PATCHES MARKET SIZE, BY DELIVERY SYSTEM, 2018-2032 (USD MILLION)
TABLE 292. UNITED STATES TRANSDERMAL PATCHES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 293. UNITED STATES TRANSDERMAL PATCHES MARKET SIZE, BY CARDIOVASCULAR DISORDERS, 2018-2032 (USD MILLION)
TABLE 294. UNITED STATES TRANSDERMAL PATCHES MARKET SIZE, BY HORMONE REPLACEMENT THERAPY, 2018-2032 (USD MILLION)
TABLE 295. UNITED STATES TRANSDERMAL PATCHES MARKET SIZE, BY PAIN MANAGEMENT, 2018-2032 (USD MILLION)
TABLE 296. UNITED STATES TRANSDERMAL PATCHES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 297. UNITED STATES TRANSDERMAL PATCHES MARKET SIZE, BY LAYER TYPE, 2018-2032 (USD MILLION)
TABLE 298. CHINA TRANSDERMAL PATCHES MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 299. CHINA TRANSDERMAL PATCHES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 300. CHINA TRANSDERMAL PATCHES MARKET SIZE, BY DRUG-IN-ADHESIVE PATCHES, 2018-2032 (USD MILLION)
TABLE 301. CHINA TRANSDERMAL PATCHES MARKET SIZE, BY MATRIX PATCHES, 2018-2032 (USD MILLION)
TABLE 302. CHINA TRANSDERMAL PATCHES MARKET SIZE, BY ACTIVE INGREDIENT, 2018-2032 (USD MILLION)
TABLE 303. CHINA TRANSDERMAL PATCHES MARKET SIZE, BY DELIVERY SYSTEM, 2018-2032 (USD MILLION)
TABLE 304. CHINA TRANSDERMAL PATCHES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 305. CHINA TRANSDERMAL PATCHES MARKET SIZE, BY CARDIOVASCULAR DISORDERS, 2018-2032 (USD MILLION)
TABLE 306. CHINA TRANSDERMAL PATCHES MARKET SIZE, BY HORMONE REPLACEMENT THERAPY, 2018-2032 (USD MILLION)
TABLE 307. CHINA TRANSDERMAL PATCHES MARKET SIZE, BY PAIN MANAGEMENT, 2018-2032 (USD MILLION)
TABLE 308. CHINA TRANSDERMAL PATCHES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 309. CHINA TRANSDERMAL PATCHES MARKET SIZE, BY LAYER TYPE, 2018-2032 (USD MILLION)

Companies Mentioned

The key companies profiled in this Transdermal Patches market report include:
  • AbbVie Inc.
  • AdhexPharma SAS
  • Amneal Pharmaceuticals, Inc.
  • Bayer AG
  • BioNxt Solutions Inc.
  • Bliss GVS Pharma Ltd.
  • Boehringer Ingelheim International GmbH
  • Corium, Inc.
  • Corsair Pharma, Inc.
  • DifGen Pharmaceuticals LLC
  • Endo International plc
  • Gedeon Richter Plc
  • GlaxoSmithKline Plc
  • Icure Pharmaceutical Inc.
  • Johnson & Johnson Services, Inc.
  • LAVIPHARM GROUP HOLDING S.A.
  • Lohmann Therapie-Systeme AG
  • Luye Pharma Group Ltd
  • Medherant Limited
  • Nitto Denko Corporation
  • Novartis AG
  • Noven Pharmaceuticals, Inc. by Hisamitsu Pharmaceutical Co., Inc.
  • Nutriband Inc
  • Perrigo Company plc
  • ProSolus, Inc.
  • Purdue Pharma L.P.
  • Sparsha Pharma International Pvt Ltd
  • Teikoku Seiyaku Co., Ltd.
  • Teva Pharmaceutical Industries Ltd.
  • Viatris Inc.
  • Zydus Group

Table Information

Report AttributeDetails
No. of Pages188
PublishedJanuary 2026
Forecast Period2026 - 2032
Estimated Market Value ( USD ) in 2026 $ 8.77 Billion
Forecasted Market Value ( USD ) by 2032 $ 12.01 Billion
Compound Annual Growth Rate5.3%
Regions CoveredGlobal
No. of Companies Mentioned32

Related Topics

Related Reports

Transdermal Skin Patches Market Report 2025 - Product Image

Transdermal Skin Patches Market Report 2025

  • Report
  • 250 Pages
  • Global
From
Transdermal Patch Market Opportunity, Patch Dosage, Price & Clinical Trials Insight 2030 - Product Image

Transdermal Patch Market Opportunity, Patch Dosage, Price & Clinical Trials Insight 2030

  • Report
  • 300 Pages
  • Global
From
Transdermal Drug Delivery System Market - Global Forecast 2026-2032 - Product Image

Transdermal Drug Delivery System Market - Global Forecast 2026-2032

  • Report
  • 197 Pages
  • Global
From
Transdermal Skin Patches Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2032 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa) - Product Image

Transdermal Skin Patches Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2032 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)

  • Report
  • 192 Pages
  • Global
From
Transdermal Medical Patches - Global Strategic Business Report - Product Image

Transdermal Medical Patches - Global Strategic Business Report

  • Report
  • 389 Pages
  • Global
From
Copyright © 2002-2026 Research and Markets. All Rights Reserved.